Floatz logo

Doxycycline

TTR Cardiac Amyloidosis

Fondazione IRCCS Policlinico San Matteo di PaviaSmall moleculePhase 3Dormant
B
61/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
46/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the TTR Cardiac Amyloidosis cohort.

Asset / SponsorPhaseRating
TAURURSODIOL
Fondazione IRCCS Policlinico San Matteo di Pavia
Phase 3BB
Acoramidis
Eidos Therapeutics, a BridgeBio company
Phase 2B
Ntla-2001
Intellia Therapeutics
Phase 1NR
Patisiran
Austin Neuromuscular Center
Early Phase 1NR
Dobutrex
Steen Hvitfeldt Poulsen
Phase 1/2NR
nnc6019-0001
Novo Nordisk A/S
Phase 3NR

Same molecule, other indications

Doxycycline is also rated in:

lymphangioleiomyomatosisDormant
BB
Indicative ·
64 / 100
View asset →
tuberous sclerosisDormant
BB
Indicative ·
64 / 100
View asset →
Chronic Pelvic Pain SyndromeDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →